Paradoxical trafficking and regulation of 5-HT2A receptors by agonists and antagonists

5-Hydroxytryptamine(2A) (serotonin(2A), 5-HT(2A)) receptors are important for many physiologic processes including platelet aggregation, smooth muscle contraction, and the modulation of mood and perception. A large number of pharmaceutical agents mediate their actions, at least in part, by modulating the number and/or activity of 5-HT(2A) receptors. Drugs with action at 5-HT(2A) receptors are used in the treatment of many disorders, including schizophrenia, depression, and anxiety disorders. This review summarizes over two decades of research on the regulation of 5-HT(2A) receptors and provides a comprehensive review of numerous in vivo studies describing the paradoxical phenomenon of 5-HT(2A) receptor down-regulation by chronic treatment with antidepressants and antipsychotics. In addition, studies reporting antagonist-induced internalization of 5-HT(2A) receptors and other G protein-coupled receptors will be highlighted as a possible mechanism to explain this paradoxical down-regulation. Finally, a review of the cellular and molecular mechanisms that may be responsible for agonist-mediated desensitization and internalization of 5-HT(2A) receptors will be presented.

[1]  A. Maggi,et al.  Differential effects of antidepressant treatment on brain monoaminergic receptors. , 1980, European journal of pharmacology.

[2]  S. Yamawaki,et al.  Homologous Desensitization of Serotonin 5‐HT2 Receptor‐Stimulated Intracellular Calcium Mobilization in C6BU‐1 Glioma Cells via a Mechanism Involving a Calmodulin Pathway , 1993, Journal of neurochemistry.

[3]  M. Caron,et al.  Molecular mechanisms of G protein-coupled receptor desensitization and resensitization. , 1998, Life sciences.

[4]  J. Benovic,et al.  Arrestin/Clathrin Interaction , 1997, The Journal of Biological Chemistry.

[5]  A. Schoups,et al.  Species dependence of adaptations at the pre- and postsynaptic serotonergic receptors following long-term antidepressant drug treatment. , 1988, Biochemical pharmacology.

[6]  G. Baker,et al.  5‐Hydroxytryptamine2 and β‐Adrenergic Receptor Regulation in Rat Brain Following Chronic Treatment with Desipramine and Fluoxetine Alone and in Combination , 1994, Journal of neurochemistry.

[7]  L. JakabR,et al.  霊長類大脳皮質の5‐ヒドロキシトリプタミン2Aセロトニン受容体 錐体細胞先端樹状突起での幻覚剤及び抗精神病剤の作用部位 , 1998 .

[8]  J. Mendels,et al.  Decrease in [3H]-serotonin binding in rat brain produced by the repeated administration of either monoamine oxidase inhibitors or centrally acting serotonin agonists , 1980, Neuropharmacology.

[9]  E. sanders-Bush,et al.  Serotonin receptor sensitivity after acute and chronic treatment with mianserin. , 1982, The Journal of pharmacology and experimental therapeutics.

[10]  B. Roth,et al.  The Multiplicity of Serotonin Receptors: Uselessly Diverse Molecules or an Embarrassment of Riches? , 2000 .

[11]  B. Roth,et al.  5-Hydroxytryptamine2-family receptors (5-hydroxytryptamine2A, 5-hydroxytryptamine2B, 5-hydroxytryptamine2C): where structure meets function. , 1998, Pharmacology & therapeutics.

[12]  M. Barbaccia,et al.  Different effects of serotonin antagonists on 3H-mianserin and 3H-ketanserin recognition sites. , 1985, Life sciences.

[13]  P. Hrdina,et al.  Possible role of protein kinase C in regulation of 5-hydroxytryptamine 2A receptors in rat brain. , 1995, Canadian journal of physiology and pharmacology.

[14]  P S Goldman-Rakic,et al.  5-Hydroxytryptamine2A serotonin receptors in the primate cerebral cortex: possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[15]  G. Stancel,et al.  Binding and function of serotonin2 receptors following chronic administration of imipramine , 1984, Neuropharmacology.

[16]  J. Scott,et al.  Down-regulation of serotonin2 but not of beta-adrenergic receptors during chronic treatment with amitriptyline is independent of stimulation of serotonin2 and beta-adrenergic receptors , 1986, Neuropharmacology.

[17]  M. Caron,et al.  A central role for beta-arrestins and clathrin-coated vesicle-mediated endocytosis in beta2-adrenergic receptor resensitization. Differential regulation of receptor resensitization in two distinct cell types. , 1997, The Journal of biological chemistry.

[18]  J. Benovic,et al.  The role of receptor kinases and arrestins in G protein-coupled receptor regulation. , 1998, Annual review of pharmacology and toxicology.

[19]  H. Meltzer,et al.  Differential Effect of Subchronic Treatment with Various Neuroleptic Agents on Serotonin2 Receptors in Rat Cerebral Cortex , 1986, Journal of neurochemistry.

[20]  B. Roth,et al.  Cell-type specific effects of endocytosis inhibitors on 5-hydroxytryptamine2A receptor desensitization and resensitization reveal an arrestin-, GRK2-, and GRK5-independent mode of regulation in human embryonic kidney 293 cells , 2001 .

[21]  C. Marsden,et al.  Evidence that chronic administration of paroxetine or fluoxetine enhances 5-HT2 receptor function in the brain of the guinea pig , 1993, Neuropharmacology.

[22]  M. Teitler,et al.  Creation of a constitutively activated state of the 5-hydroxytryptamine2A receptor by site-directed mutagenesis: inverse agonist activity of antipsychotic drugs. , 1998, The Journal of pharmacology and experimental therapeutics.

[23]  N. Shorstein,et al.  Rapid down-regulation of serotonin2 receptor binding during combined administration of tricyclic antidepressant drugs and α 2 antagonists , 1983, Neuropharmacology.

[24]  M. Pranzatelli.  Regulation of 5-HT2 receptors in rat cortex. Studies with a putative selective agonist and an antagonist. , 1991, Biochemical pharmacology.

[25]  H. Loh,et al.  Down-regulation of opiate receptor in neuroblastoma x glioma NG108-15 hybrid cells. Chloroquine promotes accumulation of tritiated enkephalin in the lysosomes. , 1984, The Journal of biological chemistry.

[26]  S H Snyder,et al.  Regulation of serotonin2 (5-HT2) receptors labeled with [3H]spiroperidol by chronic treatment with the antidepressant amitriptyline. , 1980, The Journal of pharmacology and experimental therapeutics.

[27]  M. Caron,et al.  beta-Arrestin: a protein that regulates beta-adrenergic receptor function. , 1990, Science.

[28]  J. McLean,et al.  Loss of cortical serotonin2A signal transduction in senescent rats: Reversal following inhibition of protein kinase C , 1995, Neuroscience.

[29]  J. Benovic,et al.  Arrestin/Clathrin Interaction , 1997, The Journal of Biological Chemistry.

[30]  Duncan P. Taylor,et al.  Treatment with trazodone plus phenoxybenzamine accelerates development of decreased type 2 serotonin binding in rat cortex , 1981, Neuropharmacology.

[31]  J. Leysen,et al.  Rapid desensitization and resensitization of 5-HT2 receptor mediated phosphatidyl inositol hydrolysis by serotonin agonists in quiescent calf aortic smooth muscle cells. , 1990, Life sciences.

[32]  R. Duman,et al.  Chronic Electroconvulsive Seizures Increase the Expression of Serotonin2 Receptor mRNA in Rat Frontal Cortex , 1993, Journal of neurochemistry.

[33]  B. Roth,et al.  Structure and Function of the Third Intracellular Loop of the 5‐Hydroxytryptamine2A Receptor: The Third Intracellular Loop Is α‐Helical and Binds Purified Arrestins , 1999, Journal of neurochemistry.

[34]  J. Svartengren.  Selective down-regulation of the agonist-dependent high affinity state of rat cortical 5-HT2 receptors following chronic treatment with amperozide. , 1993, Journal of receptor research.

[35]  M. Toth.  Transcriptional regulation of the 5-HT2A receptor , 1995, Behavioural Brain Research.

[36]  M. Sallese,et al.  G protein-coupled receptors: heterologous regulation of homologous desensitization and its implications. , 1996, Trends in pharmacological sciences.

[37]  John A. Peters,et al.  The 5-HT3B subunit is a major determinant of serotonin-receptor function , 1999, Nature.

[38]  W. R. Buckett,et al.  Decreased 5-HT2 but not 5-HT1 receptor binding in cortex of rat after chronic administration of dothiepin Application of the woolf plot to analysis of binding parameters , 1985, Neuropharmacology.

[39]  M. Caron,et al.  Synergistic regulation of beta2-adrenergic receptor sequestration: intracellular complement of beta-adrenergic receptor kinase and beta-arrestin determine kinetics of internalization. , 1997, Molecular pharmacology.

[40]  S H Snyder,et al.  Long-term antidepressant treatment decreases spiroperidol-labeled serotonin receptor binding. , 1980, Science.

[41]  A. Deutch,et al.  Serotonin 5‐HT2A receptors are expressed on pyramidal cells and interneurons in the rat cortex , 1997, Synapse.

[42]  Michael R. Pranzatell.  Regulation of 5-HT2 receptors in rat cortex. Studies with a putative selective agonist and an antagonist. , 1991 .

[43]  N. Koshikawa,et al.  Effects of antidepressant drug combinations on cortical 5-HT2 receptors and wet-dog shakes in rats. , 1985, European journal of pharmacology.

[44]  D. Helmeste,et al.  Unusual acute effects of antidepressants and neuroleptics on S2-serotonergic receptors. , 1983, Life sciences.

[45]  J. Benovic,et al.  Visualization of Agonist-induced Sequestration and Down-regulation of a Green Fluorescent Protein-tagged β2-Adrenergic Receptor* , 1998, The Journal of Biological Chemistry.

[46]  D. X. Freedman,et al.  Daily LSD administration selectively decreases serotonin2 receptor binding in rat brain. , 1985, European journal of pharmacology.

[47]  P. Molinoff,et al.  Effects of agonists, partial agonists, and antagonists on the regulation of 5-hydroxytryptamine2 receptors in P11 cells. , 1993, Molecular pharmacology.

[48]  R. Myers,et al.  Primary structure and functional expression of the 5HT3 receptor, a serotonin-gated ion channel. , 1991, Science.

[49]  J. Saavedra,et al.  Chronic treatment with (+/-)DOI, a psychotomimetic 5-HT2 agonist, downregulates 5-HT2 receptors in rat brain. , 1989, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

[50]  P. Molinoff,et al.  Regulation of 5-HT2A receptor mRNA in P11 cells , 1995, Behavioural Brain Research.

[51]  J. Hietala,et al.  Differential Regulation of Rat 5-HT2A and 5-HT2C Receptors after Chronic Treatment with Clozapine, Chlorpromazine and Three Putative Atypical Antipsychotic Drugs , 1995, Neuropsychopharmacology.

[52]  R. Horton,et al.  Effects of chronic oral administration of the antidepressants, desmethylimipramine and zimelidine on rat cortical GABAB binding sites: a comparison with 5‐HT2 binding site changes , 1988, British journal of pharmacology.

[53]  B. Roth,et al.  Rapid agonist-induced internalization of the 5-hydroxytryptamine2A receptor occurs via the endosome pathway in vitro. , 1996, Molecular pharmacology.

[54]  J. Mallol,et al.  Epidermal growth factor (EGF)-induced up-regulation and agonist- and antagonist-induced desensitization and internalization of A1 adenosine receptors in a pituitary-derived cell line , 1999, Brain Research.

[55]  M. Caron,et al.  G-protein-coupled receptor regulation: role of G-protein-coupled receptor kinases and arrestins. , 1996, Canadian journal of physiology and pharmacology.

[56]  R. Lefkowitz,et al.  Desensitization of G protein-coupled receptors. , 1996, Recent progress in hormone research.

[57]  Mark A. Smith,et al.  The effect of chronic imipramine administration on the densities of 5-HT1A and 5-HT2 receptors and the abundancies of 5-HT receptor and transporter mRNA in the cortex, hippocampus and dorsal raphe of three strains of rat , 1994, Brain Research.

[58]  J. Benovic,et al.  Beta-arrestin acts as a clathrin adaptor in endocytosis of the beta2-adrenergic receptor. , 1996, Nature.

[59]  C. Marsden,et al.  Chronic clozapine treatment of rats down-regulates cortical 5-HT2 receptors. , 1983, European journal of pharmacology.

[60]  P. Butler,et al.  Imipramine and tetrabenazine: effects on monoamine receptor binding sites and phosphoinositide hydrolysis. , 1989, European journal of pharmacology.

[61]  W. Kroeze,et al.  The molecular biology of serotonin receptors: therapeutic implications for the interface of mood and psychosis , 1998, Biological Psychiatry.

[62]  D. X. Freedman,et al.  Serotonin2 agonist administration down-regulates rat brain serotonin2 receptors. , 1988, Life sciences.

[63]  F. Fahrenholz,et al.  Agonist and antagonist-dependent internalization of the human vasopressin V2 receptor. , 1998, Experimental cell research.

[64]  M. Mikuni,et al.  Serotonin-induced acute desensitization of serotonin2 receptors in human platelets via a mechanism involving protein kinase C. , 1990, The Journal of pharmacology and experimental therapeutics.

[65]  D. Rubinow,et al.  Chronic buspirone treatment differentially regulates 5-HT1A and 5-HT2A receptor mRNA and binding sites in various regions of the rat hippocampus. , 1995, Brain research. Molecular brain research.

[66]  H. Loh,et al.  Visualization of time-dependent redistribution of delta-opioid receptors in neuronal cells during prolonged agonist exposure. , 1999, Brain research. Molecular brain research.

[67]  K. Kellar,et al.  Differential effects of electroconvulsive shock and antidepressant drugs on serotonin-2 receptors in rat brain. , 1981, European journal of pharmacology.

[68]  J L Benovic,et al.  Role of Clathrin-mediated Endocytosis in Agonist-induced Down-regulation of the β2-Adrenergic Receptor* , 1998, The Journal of Biological Chemistry.

[69]  B. Roth,et al.  The Dynamin-dependent, Arrestin-independent Internalization of 5-Hydroxytryptamine 2A (5-HT2A) Serotonin Receptors Reveals Differential Sorting of Arrestins and 5-HT2A Receptors during Endocytosis* 210 , 2001, The Journal of Biological Chemistry.

[70]  W. Potter,et al.  Species dependence of adaptations at the pre- and postsynaptic serotonergic receptors following long-term antidepressant drug treatment. , 1988 .

[71]  B. Roth,et al.  Clozapine and other 5-hydroxytryptamine-2A receptor antagonists alter the subcellular distribution of 5-hydroxytryptamine-2A receptors in vitro and in vivo , 1999, Neuroscience.

[72]  B. Roth,et al.  5-Hydroxytryptamine2A (5-HT2A) receptor desensitization can occur without down-regulation. , 1995, The Journal of pharmacology and experimental therapeutics.

[73]  M. Caron,et al.  The interaction of beta-arrestin with the AP-2 adaptor is required for the clustering of beta 2-adrenergic receptor into clathrin-coated pits. , 2000, The Journal of biological chemistry.

[74]  J. Edwardson,et al.  Endocytosis and recycling of G protein-coupled receptors. , 1997, Trends in pharmacological sciences.

[75]  C. Stockmeier,et al.  In vivo regulation of the serotonin-2 receptor in rat brain. , 1986, Life sciences.

[76]  J. Leysen,et al.  Gaps and peculiarities in 5-HT2 receptor studies. , 1990, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

[77]  B. Roth,et al.  Serotonin 5-HT2A receptors: molecular biology and mechanisms of regulation. , 1998, Critical reviews in neurobiology.

[78]  S. Clements-Jewery,et al.  Intact 5Ht neuroterminals are not required for 5HT2 receptor down-regulation by amitriptyline , 1982, Neuropharmacology.

[79]  D. Chuang,et al.  Role of second messengers in agonist up-regulation of 5-HT2A (5-HT2) receptor binding sites in cerebellar granule neurons: involvement of calcium influx and a calmodulin-dependent pathway. , 1995, The Journal of pharmacology and experimental therapeutics.

[80]  H. Meltzer,et al.  Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values. , 1989, The Journal of pharmacology and experimental therapeutics.

[81]  B. Roth,et al.  5-Hydroxytryptamine2 receptors coupled to phospholipase C in rat aorta: modulation of phosphoinositide turnover by phorbol ester. , 1986, The Journal of pharmacology and experimental therapeutics.

[82]  V. Klimek,et al.  EFFECTS OF REPEATED TREATMENT WITH FLUOXETINE AND CITALOPRAM, A 5‐HT UPTAKE INHIBITORS ON 5‐HT1A AND 5‐HT2 RECEPTORS IN THE RAT BRAIN. , 1994, Journal of psychiatry & neuroscience : JPN.

[83]  M. Zastrow,et al.  Downregulation of G protein-coupled receptors , 2000, Current Opinion in Neurobiology.

[84]  Stephen S. G. Ferguson,et al.  Synergistic Regulation of β2-Adrenergic Receptor Sequestration: Intracellular Complement of β-Adrenergic Receptor Kinase and β-Arrestin Determine Kinetics of Internalization , 1997 .

[85]  M. Grotewiel,et al.  Regulation of Serotonin2A Receptors in Heterologous Expression Systems , 1994, Journal of neurochemistry.

[86]  P. Molinoff,et al.  Regulation of mRNA encoding 5-HT2A receptors in P11 cells through a post-transcriptional mechanism requiring activation of protein kinase C. , 1994, The Journal of biological chemistry.

[87]  J. Leysen,et al.  5‐HT2 Receptors, Roles and Regulation , 1990, Annals of the New York Academy of Sciences.

[88]  D. A. Bergstrom,et al.  Adrenergic and serotonergic receptor binding in rat brain after chronic desmethylimipramine treatment. , 1979, The Journal of pharmacology and experimental therapeutics.

[89]  A. Ravindran,et al.  Effects of selective serotonin reuptake inhibitors on platelet serotonin parameters in major depressive disorder , 1997, Biological Psychiatry.

[90]  M. Barbaccia,et al.  Comparison of iprindole, imipramine and mianserin action on brain serotonergic and beta adrenergic receptors. , 1984, The Journal of pharmacology and experimental therapeutics.

[91]  M. Sallese,et al.  Selective regulation of Gq signaling by G protein-coupled receptor kinase 2: direct interaction of kinase N terminus with activated galphaq. , 2000, Molecular pharmacology.

[92]  D. Mckenna.  Chronic treatment with (W)DOI, a psychotomimetic 5-HT2 agonist, downregulates 5-HT2 receptors in rat brain , 1989 .

[93]  B. Roth,et al.  Serotonergic Antagonist Effects on Trafficking of Serotonin 5‐HT2A Receptors in Vitro and in Vivo a , 1998, Annals of the New York Academy of Sciences.

[94]  J. Leysen,et al.  Rapid desensitization and down-regulation of 5-HT2 receptors by DOM treatment. , 1989, European journal of pharmacology.

[95]  B. Roth,et al.  Chronic mianserin treatment decreases 5-HT2 receptor binding without altering 5-HT2 receptor mRNA levels. , 1991, European journal of pharmacology.

[96]  D. Chuang,et al.  Paradoxical increase of 5-hydroxytryptamine2 receptors and 5-hydroxytryptamine2 receptor mRNA in cerebellar granule cells after persistent 5-hydroxytryptamine2 receptor stimulation. , 1993, Molecular pharmacology.

[97]  B. Roth,et al.  G protein-coupled receptor (GPCR) trafficking in the central nervous system: relevance for drugs of abuse. , 1998, Drug and alcohol dependence.

[98]  G. Baker,et al.  Comparisons of the actions of high and low doses of the MAO inhibitor tranylcypromine on 5-HT2 binding sites in rat cortex. , 1994, Journal of neural transmission. Supplementum.

[99]  J. Mendels,et al.  Monoamine oxidase inhibitors and serotonin uptake inhibitors: differential effects on [3H]serotonin binding sites in rat brain. , 1980, The Journal of pharmacology and experimental therapeutics.

[100]  B. Roth,et al.  Regulation of 5-HT2 and 5-HT1C serotonin receptor levels. Methodology and mechanisms. , 1990, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

[101]  H. Meltzer,et al.  Effect of typical and atypical antipsychotic drugs on 5-HT2 receptor density in rat cerebral cortex. , 1989, Life sciences.

[102]  F. Fahrenholz,et al.  Agonist and Antagonist-Dependent Internalization of the Human Vasopressin V2Receptor☆ , 1998 .

[103]  M. Caron,et al.  Role of β-Arrestin in Mediating Agonist-Promoted G Protein-Coupled Receptor Internalization , 1996, Science.

[104]  A. Strosberg,et al.  Beta(2)-adrenergic receptor down-regulation. Evidence for a pathway that does not require endocytosis. , 1999, The Journal of biological chemistry.

[105]  Paul J. Harrison,et al.  The effects of clozapine and haloperidol on serotonin-1A, -2A and -2C receptor gene expression and serotonin metabolism in the rat forebrain , 1996, Neuroscience.

[106]  M. Caron,et al.  G-protein-coupled receptor kinases and arrestins: regulators of G-protein-coupled receptor sequestration. , 1996, Biochemical Society transactions.

[107]  L. Miller,et al.  Antagonist-stimulated internalization of the G protein-coupled cholecystokinin receptor. , 1997, Molecular pharmacology.

[108]  K. Ueno,et al.  [Changes in 5-HT2 receptor density induced by repeated treatment with 5-HT uptake inhibitor or 5-HT agonist]. , 1989, Yakubutsu, seishin, kodo = Japanese journal of psychopharmacology.

[109]  M. Toth,et al.  Antagonist-mediated down-regulation of 5-hydroxytryptamine type 2 receptor gene expression: modulation of transcription. , 1994, Molecular pharmacology.

[110]  P. Molinoff,et al.  Desensitization and down-regulation of 5-HT2 receptors in P11 cells. , 1991, The Journal of pharmacology and experimental therapeutics.

[111]  R. Ferris,et al.  Bupropion: A new antidepressant drug, the mechanism of action of which is not associated with down-regulation of postsynaptic β-adrenergic, serotonergic (5-HT2), α 2-adrenergic, imipramine and dopaminergic receptors in brain , 1983, Neuropharmacology.

[112]  J. Pouysségur,et al.  Distinct Mechanisms Regulate 5-HT2 and Thrombin Receptor Desensitization (*) , 1995, The Journal of Biological Chemistry.